|
Sign In to gain access to subscriptions and/or personal tools.
|
Quantification of impairment in MS: discussion of the scales in use
Maria Pia Amato
Department of Neurology, University of Florence, Viale Morgagni 85, 50134 Florence, Italy
Giuseppina Ponziani
Department of Neurology, University of Florence, Viale Morgagni 85, 50134 Florence, Italy
Accurate, efficient measurement of disease status has become a key issue in MS clinical practice and research. Despite some perceived problems, the Expanded Disability Status Scale (EDSS) remains the most widely used comprehensive measure of impairment. There is also a place for more restricted scales of impairment which focus on some aspects of neurological function in more detail than the EDSS e.g. measures of ambulation, arm function and cognitive function. Improvements in scales of impairment in the future is likely to result from the use of more quantitative tests of selected components of the neurological examination.
Key Words: EDSS • impairment scales • multiple sclerosis
Multiple Sclerosis, Vol. 5, No. 4,
216-219 (1999)
DOI: 10.1177/135245859900500404
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
O. Gray, G. McDonnell, and S. Hawkins
Tried and tested: the psychometric properties of the multiple sclerosis impact scale (MSIS-29) in a population-based study
Multiple Sclerosis,
January 1, 2009;
15(1):
75 - 80.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. Carvalho, M. Santos, P. Maciel, and F. Rodrigues
T-1237C polymorphism of TLR9 gene is not associated with multiple sclerosis in the Portuguese population
Multiple Sclerosis,
May 1, 2008;
14(4):
550 - 552.
[Abstract]
[PDF]
|
|
|
|
|
|
|
F. Patti, C. Pozzilli, E. Montanari, A. Pappalardo, L. Piazza, A. Levi, E. Onesti, I. Pesci, and the Italian Study Group on Quality of Life in MS
Effects of education level and employment status on HRQoL in early relapsing-remitting multiple sclerosis
Multiple Sclerosis,
July 1, 2007;
13(6):
783 - 791.
[Abstract]
[PDF]
|
|
|
|
|
|
|
K. Rejdak, M. J. Eikelenboom, A. Petzold, E. J. Thompson, Z. Stelmasiak, R. H.C. Lazeron, F. Barkhof, C. H. Polman, B. M.J. Uitdehaag, and G. Giovannoni
CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis
Neurology,
October 26, 2004;
63(8):
1439 - 1445.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Santos, M. do Carmo Costa, M. E. Rio, M. J. Sa, M. Monteiro, A. Valenca, A. Sa, J. Dinis, J. Figueiredo, L. B. de Almeida, et al.
Genotypes at the APOE and SCA2 loci do not predict the course of multiple sclerosis in patients of Portuguese origin
Multiple Sclerosis,
April 1, 2004;
10(2):
153 - 157.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. Petzold, M. J. Eikelenboom, D. Gveric, G. Keir, M. Chapman, R. H. C. Lazeron, M. L. Cuzner, C. H. Polman, B. M. J. Uitdehaag, E. J. Thompson, et al.
Markers for different glial cell responses in multiple sclerosis: clinical and pathological correlations
Brain,
July 1, 2002;
125(7):
1462 - 1473.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E M Cheng, R D Hays, L W Myers, G W Ellison, M Beckstrand, and B G Vickrey
Factors related to agreement between self-reported and conventional Expanded Disability Status Scale (EDSS) scores
Multiple Sclerosis,
December 1, 2001;
7(6):
405 - 410.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M P Amato, G Ponziani, F Rossi, C L Liedl, C Stefanile, and L Rossi
Quality of life in multiple sclerosis: the impact of depression, fatigue and disability
Multiple Sclerosis,
October 1, 2001;
7(5):
340 - 344.
[Abstract]
[PDF]
|
|
|
|
|
